Page 9 - Trial Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Clinicians continue their discussion of three new agents approved for the treatment of major depressive disorder (MDD).

Clinicians wrap up their discussion of three new agents approved for the treatment of major depressive disorder (MDD).

Experts shed light on the challenges of seborrheic dermatitis treatment, emphasizing the historical lack of treatment options and importance of patient education.

Learn about the type of bond he receives. >> luke, i want to turn back to jack smith's case. these new developments now, essentially, a defendant changing their testimony. what does this tell you, tell us, frankly, about how jack smith is building this case as we barreled towards some trial data sometime undetermined? >> i think a couple of things. one, i think it shows jack smith is far from done. right? he has already brought one superseding indictment and the documents case. now we see that he's getting witnesses who previously made false statements, allegedly, alleged in court, now providi...

BERLIN (Reuters) -Roche inadvertently published positive lung cancer drug trial data from an interim analysis, boosting the Swiss drug maker's shares even though more data will be needed to confirm the treatment's efficacy. Roche said on Wednesday that market participants had made it aware of the inadvertent disclosure of an interim data analysis on new immunotherapy tiragolumab, part of an experimental class of drugs known as anti-TIGIT. The read-out is not yet statistically significant, meaning that random effects cannot be ruled out with enough certainty, but a Roche spokesperso...